US 12428480
Anti-CD19 antibodies and multi-specific binding proteins
granted A61KA61K2039/505A61P
Quick answer
US patent 12428480 (Anti-CD19 antibodies and multi-specific binding proteins) held by Cullinan Therapeutics, Inc. expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cullinan Therapeutics, Inc.
- Grant date
- Tue Sep 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61P, A61P31/04, A61P35/00